ONCSQ
OncoSec Medical Inc

10,414
Loading...
Loading...
OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered in Ewing, NJ.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of OncoSec Medical Inc?
What is the 52-week high for OncoSec Medical Inc?
What is the 52-week low for OncoSec Medical Inc?
What is the 50-day moving average of OncoSec Medical Inc?

Latest ONCSQ News

View
No ONCSQ news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.